HEALTHCARE | LIFE SCIENCES & PHARMA

The Life Sciences segment realises interesting yields, which is excellent in view of the considerable risks. The difference between scientific applications and large-scale market operation often seems bigger than anticipated. Mergers and acquisitions distract from everyday management: who is to buy the business, where to find buyers, how to approach them, how to value developments? An important theme in this is arranging the financing.

The pharma sector is changing rapidly. Expiring patents, fierce competition from new markets and strict demands from insurers and users are set to drastically change the market in coming decades.

Both in the life sciences and in the pharma market we are specialised in providing assistance in the strategic and financial process. We know financiers and investors, we know where their interests lie and what they need to be able to decide. In these highly specific markets we also know how to identify buyers and sellers to achieve strategic exits. In view of its highly globalised character and strong focus on sciences and pharma, our services rely on the use of our international Corporate Finance International network.